JCN Newswire Eisai to Present Latest Data on Lemborexant at The 36th Annual Sleep 2022 Meeting TOKYO, Jun 3, 2022 – […] 2022-06-03
JCN Newswire Eisai Launches In-house Developed Anti-insomnia Drug Dayvigo (Lemborexant) In Hong Kong TOKYO, Jul 1, 2021 – […] 2021-07-01
JCN Newswire Eisai To Present Latest Data of Lemborexant at 35th Annual Sleep Meeting (SLEEP2021) TOKYO, Jun 9, 2021 – […] 2021-06-09
JCN Newswire New Drug Approval for in-House Developed Anti-Insomnia Drug Dayvigo (Lemborexant) in Hong Kong TOKYO, Mar 2, 2021 – […] 2021-03-02